期刊文献+

与小儿泌尿生殖系横纹肌肉瘤治疗相关的耐药基因研究 被引量:1

Characterization of multidrug resistance-related genes in pediatric genitourinary rhabdomyosarcoma
原文传递
导出
摘要 目的 分析小儿泌尿生殖系横纹肌肉瘤对化疗药物产生的多药耐药 (MDR)现象 ,及其对治疗效果的影响。方法  (1)用免疫组织化学的方法检测多药耐药基因 (MDR1)、多药耐药相关蛋白基因 (MRP)、肺耐药蛋白基因 (LRP)在 4 7例小儿泌尿生殖系横纹肌肉瘤病理组织中的蛋白表达 ,分别比较 3种耐药基因在横纹肌肉瘤患儿手术后 3年存活与死亡病例中的表达结果 ,以分析其与治疗效果的关系 ;(2 )用原位杂交 (ISH)的方法研究多药耐药基因 (MDR1)mRNA在小儿泌尿生殖系横纹肌肉瘤 5例复发病例新鲜肿瘤标本中的表达。 (3)做与RMS治疗相关多因素分析 ,了解MDR对治疗效果的影响。结果  (1)对 4 7例小儿泌尿生殖系横纹肌肉瘤做免疫组化检测 3种耐药基因 :MDR1阳性表达 2 1例 ,以阳性和强阳性表达为主 ,表达阴性组存活病例数多于表达阳性组 (χ2 检验 ,P <0 .0 0 5 ) ;MRP阳性表达 5例 ,以弱阳性为主 ,表达阴性组存活病例数与表达阳性组无差异 (χ2 检验 ,P >0 .0 5 ) ;LRP阳性表达 2 4例 ,以阳性和强阳性为主 ,表达阴性组存活病例数多于表达阳性组(χ2 检验 ,P <0 .0 0 5 )。 (2 )原位杂交检测 5例新鲜标本 ,4例有MDR1mRNA阳性表达。 (3)多因素分析证明MDR1及LRP与治疗效果相关。 Objective To analyse multidrug resistance(MDR) and its influence in the treatment of pediatric genitourinary rhabdomyosarcoma (RMS). Methods (1)To detect expression of multidrug resistance 1(MDR1)?multidrug resistance-associated protein (MRP) and lung resistance protein(LRP) by immunohistochemistry in 47 patients with genitourinary RMS. The survival numbers between positive and negative expression groups were compared. (2)In situ hybridization (ISH) was used to investigate mRNA expression of MDR1 in 5 fresh RMS specimens. (3) The factors related to 3 year postoperative survivals were analysed by using logistic regression. Results Immunohistochemistry examination was done in 47 RMS cases and 21 RMS had positive expression of MDR1. The survival numbers of negative expression group were higher than positive group(P< 0.005). There were only 5 RMS cases that had MRP positive expression. There was no significant difference between survival numbers of negative expression group and that of positive group(P> 0.05). 24 RMS had positive expression of LRP and survival numbers of negative expression group were also higher than that of positive group(P< 0.005). 4 had positive expression by ISH studies in 5 RMS. MDR1 and LRP were chosen by multivariate logistic regression. Conclusions MDR of pediatric genitourinary RMS could be detected by measuring the levels of protein and mRNA. High MDR1 and LRP expression were found in RMS and they had close relationship with the outcome of treatment. MRP expression was low and had no significant correlation with outcome.
出处 《中华小儿外科杂志》 CSCD 北大核心 2004年第2期133-136,共4页 Chinese Journal of Pediatric Surgery
关键词 小儿 泌尿生殖系肿瘤 横纹肌肉瘤 耐药基因 化疗 免疫组织化学 Rhabdomyosarcoma Drug resistance,multiple P-glycoprotein Multidrug resistance gene
  • 相关文献

参考文献9

  • 1Kaefer M, Rick RC. Genitourinary rhabdomyosarcoma. Urol Clin North Am, 2000,27:471-487.
  • 2Chan HS, Thomer PS, Haddad G, et al. Immunohistochemical detection of P-gp: prognostic correlation in soft sarcoma of childhood.J Clin Oncol, 1990,8:689-704.
  • 3Cocker HA, Pinkerton CR, Kelland LR. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma.Br J Cancer, 2000, 83:338-345.
  • 4Prados J, Melguizo C, Marchal JA, et al. Multidrug resistance phenotype in the RMS-GR hurman rhabdomyosarcoma cell line obtained after polychemotherapy, 1999,90: 788-793.
  • 5Chan HS, Grogan TM, Haddad G, et at. Standardization of a single-cell assay for sensitive detection of Multidrug resistance protein expression in normal and malignant cells in archival clinical samples.J Lab Clin Med, 1997,130:297-306.
  • 6Vergier B, Cany L, Bonnet F, et al. Expression of MDR1/Pglycoprotein in human sarcomas. Br J Cancer, 1993, 68:1221-1226.
  • 7魏寿江,骆云鹏,王严庆.肿瘤耐药性研究的新进展[J].国外医学(临床生物化学与检验学分册),2001,22(1):30-31. 被引量:3
  • 8夏春燕,刘会敏.检测MDR_1/P-gp临床意义的研究进展[J].诊断病理学杂志,2000,7(2):142-144. 被引量:10
  • 9步星耀,金百祥,何志明.小儿常见恶性实体瘤多药耐药性蛋白的定位检测[J].中华小儿外科杂志,1995,16(5):262-264. 被引量:4

二级参考文献7

共引文献15

同被引文献13

  • 1Weiss SW, Goldblum J. Rhabdomyosarcoma. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's soft tissue tumors. St. Louis: CV Mosby,200l. 785-835.
  • 2Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV:results for patients with nonmetastatic dis ease. J Clin Oncol,2001,19(12) :3091-3102.
  • 3Hawkins WG, Hoos A, Antonescu CR, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer, 2001,91 (4) ;794-803.
  • 4Nascimento AF. Rhabdomyosarcomas in adults: classification and differential diagnosis. Diagnostic Histopathology, 2008, 14 ( 11 ) : 538-545.
  • 5Hayes-Jordan A,Andrassy R. Rhabdomyosarcoma in children. Curr Opin Pediatr,2009,21 (3):373-378.
  • 6Komdeur R, Klunder J, van der Graaf WT, et al. Multidrug Resistance Proteins in Rhabdomyosarcomas Comparison between Children and Adults. Cancer, 2003,97 (8) : 1999-2005.
  • 7Rafsanjani KA, Vossough P, Bashardoust A, et al. Survival rate of children with rhabdomyosarcoma and prognostic factors. World J Pediatr, 2007,3 ( 1 ) : 36-40.
  • 8Esnaola NF,Rubin BP, Baldini EH, et al. Response to chemo therapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg,2001,234(2) : 215-223.
  • 9Sultan I, Qaddoumi I, Yaser S, et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol,2009,27(20) : 3391-3397.
  • 10Leaphart C,Rodeberg D. Pediatric surgical oncology: management of rhabdomyosarcoma. Surg Oncol, 2007, 16 (3) : 173-185.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部